Literature DB >> 6272089

Regulation of cyclic AMP metabolism in human platelets. Sequential activation of adenylate cyclase and cyclic AMP phosphodiesterase by prostaglandins.

R Alvarez, A Taylor, J J Fazzari, J R Jacobs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6272089

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN： 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  10 in total

1.  A uniform extracellular stimulus triggers distinct cAMP signals in different compartments of a simple cell.

Authors:  T C Rich; K A Fagan; T E Tse; J Schaack; D M Cooper; J W Karpen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

2.  Immunological identification of the major platelet low-Km cAMP phosphodiesterase: probable target for anti-thrombotic agents.

Authors:  C H Macphee; S A Harrison; J A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

3.  AH6809, a prostaglandin DP-receptor blocking drug on human platelets.

Authors:  R J Keery; P Lumley
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

4.  cAMP-mediated phosphorylation of the low-Km cAMP phosphodiesterase markedly stimulates its catalytic activity.

Authors:  P G Grant; A F Mannarino; R W Colman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

Review 5.  Milestones in the development and implementation of FRET-based sensors of intracellular signals: A biological perspective of the history of FRET.

Authors:  J Deal; D J Pleshinger; S C Johnson; S J Leavesley; T C Rich
Journal:  Cell Signal       Date:  2020-09-06       Impact factor: 4.315

6.  The rabbit as an intracavernous injection study model.

Authors:  Y M Lin; J S Lin
Journal:  Urol Res       Date:  1996

7.  Complex regulation of calcium current in cardiac cells. Dependence on a pertussis toxin-sensitive substrate, adenosine triphosphate, and an alpha 1-adrenoceptor.

Authors:  E C Keung; J S Karliner
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

Review 8.  Phosphodiesterases maintain signaling fidelity via compartmentalization of cyclic nucleotides.

Authors:  Oliver Lomas; Manuela Zaccolo
Journal:  Physiology (Bethesda)       Date:  2014-03

9.  Variations in Intraplatelet Phospho-VASP Expression Due to Pre-analytical Sample Preparations, Illustration of a Quality Control Issue in Platelet Pharmacology.

Authors:  Ahmad Gharehbaghian; Morteza Salimian; Ali Akbar Taherian; Asghar Elahi; Tahereh Khamechian; Gharib Karimi; Mehran Ghasemzadeh
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

10.  Docking and quantitative structure-activity relationship of bi-cyclic heteroaromatic pyridazinone and pyrazolone derivatives as phosphodiesterase 3A (PDE3A) inhibitors.

Authors:  Camila Muñoz-Gutiérrez; Daniela Cáceres-Rojas; Francisco Adasme-Carreño; Iván Palomo; Eduardo Fuentes; Julio Caballero
Journal:  PLoS One       Date:  2017-12-07       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.